Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients
Erkens, J.A., Klungel, O.H., Herings, R.M.C., Stolk, R.P., Spoelstra, J.A., Grobbee, D.E., Leufkens, H.G.M.
Published in European heart journal (01.10.2002)
Published in European heart journal (01.10.2002)
Get full text
Journal Article